Psychometric validation of the Chinese version of the M. D. Anderson Symptom Inventory-Head and Neck Module in patients with nasopharyngeal carcinoma

被引:1
|
作者
Xiao, Wenli [1 ]
Chan, Carmen W. H. [2 ]
Wang, Xin Shelley [3 ]
Xiao, Jinnan [4 ]
Ng, Marques S. N. [2 ,5 ]
机构
[1] Guangzhou Univ Chinese Med, Sch Nursing, Guangzhou, Peoples R China
[2] Chinese Univ Hong Kong, Nethersole Sch Nursing, Hong Kong, Peoples R China
[3] Univ Texas MD Anderson Canc Ctr, Dept Symptom Res, Houston, TX 77030 USA
[4] Cent South Univ, Xiangya Sch Nursing, Changsha, Peoples R China
[5] Chinese Univ Hong Kong, Hong Kong, Peoples R China
关键词
Nasopharyngeal carcinoma; Head and neck cancer; Symptom burden; MDASI-HN; Validation; QUALITY-OF-LIFE; CANCER-PATIENTS; PSYCHOEDUCATIONAL INTERVENTION; TAIWANESE VERSION; DISTRESS; UTILITY; RADIOTHERAPY; INSTRUMENT; SURVIVORS; CLUSTERS;
D O I
10.1016/j.apjon.2021.12.014
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Objective:The Chinese version of the M. D. Anderson Symptom Inventory-Head and Neck Module (MDASI-HN-C) has been linguistically validated. However, its psychometric properties have not been established yet. The purpose of the study was to psychometrically validate the MDASI-HN-C in patients with nasopharyngeal carcinoma (NPC). Methods:130 Chinese NPC patients who were undergoing radiotherapy (RT) participated in this cross-sectional study. The content, convergent, and construct validity of the MDASI-HN-C were examined. The reliability of the instrument was tested by examining the internal consistency and test-retest reliability. Results:Cronbach's alpha coefficients ranged from 0.85 to 0.91 for the three subscales of the MDASI-HN-C. The 3-day test-retest reliability was acceptable with intraclass correlation coefficients (ICC) ranged from 0.52 to 0.71. The scale content validity index (S-CVI) was satisfactory (0.97). Subscale scores of the MDASI-HN-C were negatively correlated with the total score of the Chinese version of the Functional Assessment of Cancer Therapy-Head and Neck Scale (FACT-H&N-C) as hypothesized (r 1/4 -0.484 to -0.563, all P < 0.01). Exploratory factor analysis (EFA) revealed two factors for the 13 core and another two for the nine HNC-specific items. Only one factor was generated for the six interference items. Conclusions:The MDASI-HN-C shows desirable psychometric properties for evaluating symptom burden in NPC patients, which can be used in both clinical and research contexts.
引用
收藏
页码:113 / 118
页数:6
相关论文
共 50 条
  • [21] VALIDATION OF THE M. D. ANDERSON SYMPTOM INVENTORY SPINE TUMOR MODULE (MDASI-SP)
    Armstrong, Terri
    Gning, Ibrahima
    Mendoza, Tito
    Vera, Elizabeth
    Gilbert, Mark
    Rhines, Laurence
    Weinberg, Jeffrey
    Sanchez-Williams, Gisella
    Levin, Victor
    Burton, Allen
    Grossman, Tracy
    Cleeland, Charles
    NEURO-ONCOLOGY, 2008, 10 (05) : 876 - 876
  • [22] Validation of the M. D. Anderson symptom inventory (MDASI-BT).
    Armstrong, T. S.
    Mendoza, T.
    Gning, I.
    Coco, C.
    Gilbert, M. R.
    Cleeland, C.
    Cohen, M. Z.
    Eriksen, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 69S - 69S
  • [23] Linguistic Validation of the Turkish Version of the MD Anderson Symptom Inventory - Head and Neck Cancer Module
    Gunn, G. Brandon
    Atalar, Banu
    Mendoza, Tito R.
    Cleeland, Charles S.
    Selek, Ugur
    Ozyar, Enis
    Rosenthal, David I.
    BALKAN MEDICAL JOURNAL, 2016, 33 (03) : 339 - 343
  • [24] Symptom Profiles in Patients with Chronic Lymphocytic Leukemia: Validation and Application of the M. D. Anderson Symptom Inventory
    Wang, Xin Shelley
    Mendoza, Tito R.
    Broadway, Jackie B.
    Mobley, Gary M.
    Keating, Michael
    Cleeland, Charles S.
    Ferrajoli, Alessandra
    BLOOD, 2009, 114 (22) : 567 - 567
  • [25] Assessing symptom distress in cancer patients - The M. D. Anderson Symptom Inventory
    Cleeland, CS
    Mendoza, TR
    Wang, XS
    Chou, C
    Harle, MT
    Morrissey, M
    Engstrom, MC
    CANCER, 2000, 89 (07) : 1634 - 1646
  • [26] Chinese version of the M.D. Anderson Symptom Inventory - Validation and application of symptom measurement in cancer patients
    Wang, XS
    Wang, Y
    Guo, H
    Mendoza, TR
    Hao, XS
    Cleeland, CS
    CANCER, 2004, 101 (08) : 1890 - 1901
  • [27] Validation of the Swedish M. D. Anderson Dysphagia Inventory (MDADI) in Patients with Head and Neck Cancer and Neurologic Swallowing Disturbances
    Carlsson, Sigrid
    Ryden, Anna
    Rudberg, Ingrid
    Bove, Mogens
    Bergquist, Henrik
    Finizia, Caterina
    DYSPHAGIA, 2012, 27 (03) : 361 - 369
  • [28] Validation of the Swedish M. D. Anderson Dysphagia Inventory (MDADI) in Patients with Head and Neck Cancer and Neurologic Swallowing Disturbances
    Sigrid Carlsson
    Anna Rydén
    Ingrid Rudberg
    Mogens Bove
    Henrik Bergquist
    Caterina Finizia
    Dysphagia, 2012, 27 : 361 - 369
  • [29] Psychometric Properties of the Chinese Version of the MD Anderson Dysphagia Inventory for Head and Neck Cancer Patients
    Zhang, Li-Juan
    Jiang, Nan
    Li, Zheng
    Chen, Xi-Wei
    Wang, Pei-Guo
    Wang, Xin
    Zhao, Yue
    CANCER NURSING, 2017, 40 (03) : E9 - E16
  • [30] Linguistic Validation of the M. D. Anderson Symptom Inventory in Persian-Speaking Iranian Cancer Patients
    Saadatpour, Leila
    Hemati, Simin
    Habibi, Farzaneh
    Behzadi, Erfan
    Hashemi-Jazi, Marsa Sadat
    Kheirabadi, Gholamreza
    Mirbagher, Leila
    Gholamrezaei, Ali
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2015, 50 (03) : 387 - +